v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development $ 15,598 $ 19,435
Selling, general and administrative 5,222 5,324
Total operating expenses 20,820 24,759
Loss from operations (20,820) (24,759)
Other income (expense), net:    
Interest income, net 593 503
Change in fair value of notes payable (610) (283)
Change in fair value of warrant liabilities 30,055 825
Other expense, net   (21)
Total other income, net 30,038 1,024
Net income (loss) and comprehensive income (loss) $ 9,218 $ (23,735)
Net income (loss) per share, basic $ 0.06 $ (0.49)
Net income (loss) per share, diluted $ 0.06 $ (0.49)
Weighted-average number of common shares outstanding, basic 158,492,158 48,865,468
Weighted-average number of common shares outstanding, diluted 158,492,158 48,865,468